Back to Search

Semaglutide – Uses, Dosage, and Brands in UAE

Brand Name: OZEMPIC 0.5
Strength: 0.5 mg/dose | Form: Solution For Injection
Price in UAE: AED 743.50
Available in UAE pharmacies

About Semaglutide

Class: | GLP-1 receptor agonist Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight with at least one weight-related comorbidity. Adult dose: | Initial dose is 0.25 mg once weekly for 4 weeks; may increase to 0.5 mg once weekly. After at least 4 weeks on 0.5 mg, the dose may be increased to 1 mg once weekly if additional glycemic control is needed. Pediatric dose: | Safety and

Drug Class

GLP-1 receptor agonist

Uses & Indications

Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight with at least one weight-related comorbidity.

Storage Requirements

Store in a refrigerator (36°F to 46°F or 2°C to 8°C). Once in use, it can be stored at room temperature (up to 86°F or 30°C) for up to 56 days.

Manufacturer & Packaging

Manufacturer: Novo Nordisk A/S, DENMARK

Package Size

1 Prefilled Pen (1.5ml) + 4 Disposable NovoFine Plus Needles

Price & Supplier

Price in UAE: AED 743.50

Dosage Information

Adult Dose

Initial dose is 0.25 mg once weekly for 4 weeks; may increase to 0.5 mg once weekly. After at least 4 weeks on 0.5 mg, the dose may be increased to 1 mg once weekly if additional glycemic control is needed.

Pediatric Dose

Safety and efficacy have not been established in pediatric patients under 18 years of age.

Side Effects

Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite.

Contraindications & Precautions

Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in patients with a history of serious hypersensitivity reactions to semaglutide or any of its components.

Important Warnings

Risk of thyroid C-cell tumors; pancreatitis; renal impairment; hypoglycemia when used with other antidiabetic medications; and not recommended for use in patients with severe gastrointestinal disease.

Other Brands & Strengths Available in UAE

Different brands and strengths of Semaglutide available in UAE pharmacies:

OZEMPIC 0.25 mg/1.5ml Solution For Injection OZEMPIC 0.5 mg/1.5ml Solution For Injection OZEMPIC 1 mg/1.5ml Solution For Injection OZEMPIC 0.25 0.25 mg/dose Solution For Injection OZEMPIC 0.5 0.5 mg/dose Solution For Injection OZEMPIC 1 1 mg/dose Solution For Injection RYBELSUS 14 mg Tablets RYBELSUS 3 mg Tablets RYBELSUS 7 mg Tablets Wegovy FlexTouch 0.25 mg/dose Solution for Subcutaneous Injection

Related Medicines in Same Category

See also: Other GLP-1 receptor agonist medicines available in UAE pharmacies

Dulaglutide Dulaglutide Dulaglutide Dulaglutide Exenatide Exenatide Exenatide Liraglutide

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All GLP-1 receptor agonist Medicines Browse All Categories